These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 30567982

  • 1. Resistance to Second-Generation HIV-1 Maturation Inhibitors.
    Urano E, Timilsina U, Kaplan JA, Ablan S, Ghimire D, Pham P, Kuruppu N, Mandt R, Durell SR, Nitz TJ, Martin DE, Wild CT, Gaur R, Freed EO.
    J Virol; 2019 Mar 15; 93(6):. PubMed ID: 30567982
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A single G10T polymorphism in HIV-1 subtype C Gag-SP1 regulates sensitivity to maturation inhibitors.
    Ghimire D, Kc Y, Timilsina U, Goel K, Nitz TJ, Wild CT, Gaur R.
    Retrovirology; 2021 Apr 09; 18(1):9. PubMed ID: 33836787
    [Abstract] [Full Text] [Related]

  • 4. Insight into the mechanism of action of EP-39, a bevirimat derivative that inhibits HIV-1 maturation.
    Neyret A, Gay B, Cransac A, Briant L, Coric P, Turcaud S, Laugâa P, Bouaziz S, Chazal N.
    Antiviral Res; 2019 Apr 09; 164():162-175. PubMed ID: 30825471
    [Abstract] [Full Text] [Related]

  • 5. In vitro resistance to the human immunodeficiency virus type 1 maturation inhibitor PA-457 (Bevirimat).
    Adamson CS, Ablan SD, Boeras I, Goila-Gaur R, Soheilian F, Nagashima K, Li F, Salzwedel K, Sakalian M, Wild CT, Freed EO.
    J Virol; 2006 Nov 09; 80(22):10957-71. PubMed ID: 16956950
    [Abstract] [Full Text] [Related]

  • 6. Structural and functional insights into the HIV-1 maturation inhibitor binding pocket.
    Waki K, Durell SR, Soheilian F, Nagashima K, Butler SL, Freed EO.
    PLoS Pathog; 2012 Nov 09; 8(11):e1002997. PubMed ID: 23144615
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Impact of human immunodeficiency virus type 1 resistance to protease inhibitors on evolution of resistance to the maturation inhibitor bevirimat (PA-457).
    Adamson CS, Waki K, Ablan SD, Salzwedel K, Freed EO.
    J Virol; 2009 May 09; 83(10):4884-94. PubMed ID: 19279107
    [Abstract] [Full Text] [Related]

  • 10. Polymorphisms in Gag spacer peptide 1 confer varying levels of resistance to the HIV- 1 maturation inhibitor bevirimat.
    Adamson CS, Sakalian M, Salzwedel K, Freed EO.
    Retrovirology; 2010 Apr 20; 7():36. PubMed ID: 20406463
    [Abstract] [Full Text] [Related]

  • 11. The prototype HIV-1 maturation inhibitor, bevirimat, binds to the CA-SP1 cleavage site in immature Gag particles.
    Nguyen AT, Feasley CL, Jackson KW, Nitz TJ, Salzwedel K, Air GM, Sakalian M.
    Retrovirology; 2011 Dec 07; 8():101. PubMed ID: 22151792
    [Abstract] [Full Text] [Related]

  • 12. A single polymorphism in HIV-1 subtype C SP1 is sufficient to confer natural resistance to the maturation inhibitor bevirimat.
    Lu W, Salzwedel K, Wang D, Chakravarty S, Freed EO, Wild CT, Li F.
    Antimicrob Agents Chemother; 2011 Jul 07; 55(7):3324-9. PubMed ID: 21502630
    [Abstract] [Full Text] [Related]

  • 13. HIV-1 maturation inhibitor bevirimat stabilizes the immature Gag lattice.
    Keller PW, Adamson CS, Heymann JB, Freed EO, Steven AC.
    J Virol; 2011 Feb 07; 85(4):1420-8. PubMed ID: 21106735
    [Abstract] [Full Text] [Related]

  • 14. Phenotypic susceptibility to bevirimat in isolates from HIV-1-infected patients without prior exposure to bevirimat.
    Margot NA, Gibbs CS, Miller MD.
    Antimicrob Agents Chemother; 2010 Jun 07; 54(6):2345-53. PubMed ID: 20308382
    [Abstract] [Full Text] [Related]

  • 15. HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat.
    Fun A, van Maarseveen NM, Pokorná J, Maas RE, Schipper PJ, Konvalinka J, Nijhuis M.
    Retrovirology; 2011 Aug 24; 8():70. PubMed ID: 21864346
    [Abstract] [Full Text] [Related]

  • 16. The capsid-spacer peptide 1 Gag processing intermediate is a dominant-negative inhibitor of HIV-1 maturation.
    Checkley MA, Luttge BG, Soheilian F, Nagashima K, Freed EO.
    Virology; 2010 Apr 25; 400(1):137-44. PubMed ID: 20172577
    [Abstract] [Full Text] [Related]

  • 17. HIV-1 Maturation: Lessons Learned from Inhibitors.
    Kleinpeter AB, Freed EO.
    Viruses; 2020 Aug 26; 12(9):. PubMed ID: 32858867
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Insights into the activity of maturation inhibitor PF-46396 on HIV-1 clade C.
    Ghimire D, Timilsina U, Srivastava TP, Gaur R.
    Sci Rep; 2017 Mar 02; 7():43711. PubMed ID: 28252110
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.